Sole Source Boston Scientific Corp Y-90 glass Theraspheres

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY HCD WEST

Contract Value

Not provided

Codes & Classification
Solicitation Number

HT941026N0096

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

Tripler Army Medical Center, Hawaii, UNITED STATES

SourceSAM
Documents2
The Defense Health Agency HCD West, operating under the Department of Defense, has issued a Special Notice of Intent to award a sole source procurement for Boston Scientific Corp’s Y-90 glass Theraspheres. This procurement, identified by HT941026N0096, is specifically intended for Tripler Army Medical Center located in Hawaii. The notice, currently active and posted on July 30, 2026, outlines the agency’s plan to secure these pharmaceutical preparations without competition, citing Boston Scientific Corp as the exclusive provider. The scope of this procurement centers on the acquisition of Y-90 glass Theraspheres, a specialized radiopharmaceutical product used in targeted cancer therapies. The intended outcome is to ensure uninterrupted access to these critical therapeutic agents for patient care at Tripler Army Medical Center. The procurement falls under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), with Product Service Code 6505, indicating its classification as a pharmaceutical supply. Key requirements include the provision of genuine Boston Scientific Y-90 glass Theraspheres, delivered in accordance with the medical and regulatory standards necessary for use in a federal healthcare facility. The notice does not specify any set-aside requirements, making it open to all qualified suppliers; however, the sole source designation restricts competition to Boston Scientific Corp due to the proprietary nature of the product. The contracting entity is the Defense Health Agency HCD West, a federal office responsible for healthcare delivery within the Department of Defense. The primary point of contact for this procurement is Cha-On Gordon ([email protected], 726-203-0109), with Mariangela Monsalve serving as the secondary contact ([email protected], 726-203-0120). Interested parties may review the notice and its attachments via the SAM.gov opportunity link provided. Contractors evaluating this opportunity should note that the procurement is a sole source action, with no set-aside or competitive bidding anticipated. The requirement is for a highly specialized pharmaceutical product, and the place of performance is Tripler Army Medical Center in Hawaii. The contract will be managed by the Defense Health Agency, ensuring compliance with federal acquisition and healthcare standards throughout its lifecycle. For further information or to express interest, contractors should refer to the official notice on SAM.gov (Opportunity ID: b054e8a2da374c4cbb8cf81732f6dd55) and direct inquiries to the listed contacts before the response deadline of August 13, 2026.